1039 related articles for article (PubMed ID: 29776961)
21. Long-term prognostic value of mid-regional pro-adrenomedullin and C-terminal pro-endothelin-1 in patients with acute myocardial infarction.
Behnes M; Papassotiriou J; Walter T; Fiedler E; Sauer T; Lang S; Elmas E; Hoffmann U; Borggrefe M; Brueckmann M
Clin Chem Lab Med; 2008; 46(2):204-11. PubMed ID: 18076360
[TBL] [Abstract][Full Text] [Related]
22. The vasoactive peptide MR-pro-adrenomedullin in COVID-19 patients: an observational study.
Gregoriano C; Koch D; Kutz A; Haubitz S; Conen A; Bernasconi L; Hammerer-Lercher A; Saeed K; Mueller B; Schuetz P
Clin Chem Lab Med; 2021 Apr; 59(5):995-1004. PubMed ID: 33554516
[TBL] [Abstract][Full Text] [Related]
23. Association of MR-proadrenomedullin with cardiovascular risk factors and subclinical cardiovascular disease.
Neumann JT; Tzikas S; Funke-Kaiser A; Wilde S; Appelbaum S; Keller T; Ojeda-Echevarria F; Zeller T; Zwiener I; Sinning CR; Jagodzinski A; Schnabel RB; Lackner KJ; Münzel T; Blankenberg S; Wild PS; Sydow K
Atherosclerosis; 2013 Jun; 228(2):451-9. PubMed ID: 23562132
[TBL] [Abstract][Full Text] [Related]
24. Prognostic impact of prepercutaneous coronary intervention TIMI flow in patients with ST-segment and non-ST-segment elevation myocardial infarction: Results from the FAST-MI 2010 registry.
Bailleul C; Aissaoui N; Cayla G; Dillinger JG; Jouve B; Schiele F; Ferrières J; Simon T; Danchin N; Puymirat E;
Arch Cardiovasc Dis; 2018 Feb; 111(2):101-108. PubMed ID: 28939193
[TBL] [Abstract][Full Text] [Related]
25. Association of Anemia With Outcomes Among ST-Segment-Elevation Myocardial Infarction Patients Receiving Primary Percutaneous Coronary Intervention.
Moghaddam N; Wong GC; Cairns JA; Goodman SG; Perry-Arnesen M; Tocher W; Mackay M; Singer J; Lee T; Rao SV; Fordyce CB
Circ Cardiovasc Interv; 2018 Dec; 11(12):e007175. PubMed ID: 30562086
[TBL] [Abstract][Full Text] [Related]
26. Midregional proadrenomedullin (MR-proADM) in the risk stratification of patients with acute pulmonary embolism.
Pedowska-Włoszek J; Kostrubiec M; Kurnicka K; Ciurzynski M; Palczewski P; Pruszczyk P
Thromb Res; 2013 Nov; 132(5):506-10. PubMed ID: 24060192
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of mid-regional pro-adrenomedullin levels taken on admission and discharge in non-ST-elevation myocardial infarction: the LAMP (Leicester Acute Myocardial Infarction Peptide) II study.
Dhillon OS; Khan SQ; Narayan HK; Ng KH; Struck J; Quinn PA; Morgenthaler NG; Squire IB; Davies JE; Bergmann A; Ng LL
J Am Coll Cardiol; 2010 Jul; 56(2):125-33. PubMed ID: 20620726
[TBL] [Abstract][Full Text] [Related]
28. Midregional proadrenomedullin predicts mortality and major adverse cardiac events in patients presenting with chest pain: results from the CHOPIN trial.
Shah KS; Marston NA; Mueller C; Neath SX; Christenson RH; McCord J; Nowak RM; Vilke GM; Daniels LB; Hollander JE; Apple FS; Cannon CM; Nagurney J; Schreiber D; deFilippi C; Hogan CJ; Diercks DB; Limkakeng A; Anand IS; Wu AH; Clopton P; Jaffe AS; Peacock WF; Maisel AS
Acad Emerg Med; 2015 May; 22(5):554-63. PubMed ID: 25908114
[TBL] [Abstract][Full Text] [Related]
29. Fractional Flow Reserve-Guided Complete Revascularization Improves the Prognosis in Patients With ST-Segment-Elevation Myocardial Infarction and Severe Nonculprit Disease: A DANAMI 3-PRIMULTI Substudy (Primary PCI in Patients With ST-Elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization).
Lønborg J; Engstrøm T; Kelbæk H; Helqvist S; Kløvgaard L; Holmvang L; Pedersen F; Jørgensen E; Saunamäki K; Clemmensen P; De Backer O; Ravkilde J; Tilsted HH; Villadsen AB; Aarøe J; Jensen SE; Raungaard B; Køber L; Høfsten DE;
Circ Cardiovasc Interv; 2017 Apr; 10(4):. PubMed ID: 28404623
[TBL] [Abstract][Full Text] [Related]
30. Elevated serum uric acid is associated with a greater inflammatory response and with short- and long-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Mandurino-Mirizzi A; Cornara S; Somaschini A; Demarchi A; Galazzi M; Puccio S; Montalto C; Crimi G; Ferlini M; Camporotondo R; Gnecchi M; Ferrario M; Oltrona-Visconti L; De Ferrari GM
Nutr Metab Cardiovasc Dis; 2021 Feb; 31(2):608-614. PubMed ID: 33358717
[TBL] [Abstract][Full Text] [Related]
31. High cystatin C levels predict long-term mortality in patients with ST-segment elevation myocardial infarction undergoing late percutaneous coronary intervention: A retrospective study.
Chen Y; Fan Y; Men M; Shen G; Ma A
Clin Cardiol; 2019 May; 42(5):572-578. PubMed ID: 30907012
[TBL] [Abstract][Full Text] [Related]
32. The influence of diabetes mellitus on midregional proadrenomedullin concentrations and prognostic value in heart failure outpatients.
Holmager P; Schou M; Egstrup M; Gustafsson I; Goetze JP; Gustafsson F; Klausen TW; Faber J; Kistorp C
J Card Fail; 2015 Mar; 21(3):250-7. PubMed ID: 25528198
[TBL] [Abstract][Full Text] [Related]
33. Predictive value of neutrophil to lymphocyte ratio in patients with acute ST segment elevation myocardial infarction after percutaneous coronary intervention: a meta-analysis.
Zhang S; Diao J; Qi C; Jin J; Li L; Gao X; Gong L; Wu W
BMC Cardiovasc Disord; 2018 May; 18(1):75. PubMed ID: 29716535
[TBL] [Abstract][Full Text] [Related]
34. Prognostic value of plasma DPP4 activity in ST-elevation myocardial infarction.
Li JW; Chen YD; Chen WR; You Q; Li B; Zhou H; Zhang Y; Han TW
Cardiovasc Diabetol; 2017 Jun; 16(1):72. PubMed ID: 28587613
[TBL] [Abstract][Full Text] [Related]
35. Mid-regional pro-adrenomedullin and copeptin to predict short-term prognosis of COPD exacerbations: a multicenter prospective blinded study.
Dres M; Hausfater P; Foissac F; Bernard M; Joly LM; Sebbane M; Philippon AL; Gil-Jardiné C; Schmidt J; Maignan M; Treluyer JM; Roche N
Int J Chron Obstruct Pulmon Dis; 2017; 12():1047-1056. PubMed ID: 28408815
[TBL] [Abstract][Full Text] [Related]
36. Discordant cardiac biomarker levels independently predict outcome in ST-segment elevation myocardial infarction.
Leibundgut G; Gick M; Morel O; Ferenc M; Werner KD; Comberg T; Kienzle RP; Buettner HJ; Neumann FJ
Clin Res Cardiol; 2016 May; 105(5):432-40. PubMed ID: 26563201
[TBL] [Abstract][Full Text] [Related]
37. Pro-A-type natriuretic peptide, proadrenomedullin, and N-terminal pro-B-type natriuretic peptide used in a multimarker strategy in primary health care in risk assessment of patients with symptoms of heart failure.
Alehagen U; Dahlström U; Rehfeld JF; Goetze JP
J Card Fail; 2013 Jan; 19(1):31-9. PubMed ID: 23273592
[TBL] [Abstract][Full Text] [Related]
38. Prognostic importance of mechanical dyssynchrony in predicting heart failure development after ST-segment elevation myocardial infarction.
Noringriis I; Modin D; Pedersen SH; Jensen JS; Biering-Sørensen T
Int J Cardiovasc Imaging; 2019 Jan; 35(1):87-97. PubMed ID: 30143920
[TBL] [Abstract][Full Text] [Related]
39. Comparison of long-term prognostic value of N-terminal-proBNP and midregional-pro-adrenomedullin in patients with acute myocardial infarction.
Walter T; Brueckmann M; Lang S; Sauer T; Fiedler E; Papassotiriou J; Behnes M; Elmas E; Borggrefe M; Bertsch T
Clin Lab; 2010; 56(7-8):303-9. PubMed ID: 20857894
[TBL] [Abstract][Full Text] [Related]
40. Association of serum transaminases with short- and long-term outcomes in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Gao M; Cheng Y; Zheng Y; Zhang W; Wang L; Qin L
BMC Cardiovasc Disord; 2017 Jan; 17(1):43. PubMed ID: 28129742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
